These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34848552)

  • 1. Brain structure and function in people recovering from COVID-19 after hospital discharge or self-isolation: a longitudinal observational study protocol.
    MacIntosh BJ; Ji X; Chen JJ; Gilboa A; Roudaia E; Sekuler AB; Gao F; Chad JA; Jegatheesan A; Masellis M; Goubran M; Rabin J; Lam B; Cheng I; Fowler R; Heyn C; Black SE; Graham SJ
    CMAJ Open; 2021; 9(4):E1114-E1119. PubMed ID: 34848552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue.
    Hosp JA; Reisert M; Dressing A; Götz V; Kellner E; Mast H; Arndt S; Waller CF; Wagner D; Rieg S; Urbach H; Weiller C; Schröter N; Rau A
    Nat Commun; 2024 May; 15(1):4256. PubMed ID: 38762609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China.
    Zhang X; Wang F; Shen Y; Zhang X; Cen Y; Wang B; Zhao S; Zhou Y; Hu B; Wang M; Liu Y; Miao H; Jones P; Ma X; He Y; Cao G; Cheng L; Li L
    JAMA Netw Open; 2021 Sep; 4(9):e2127403. PubMed ID: 34586367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
    Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
    BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations.
    Kausel L; Figueroa-Vargas A; Zamorano F; Stecher X; Aspé-Sánchez M; Carvajal-Paredes P; Márquez-Rodríguez V; Martínez-Molina MP; Román C; Soto-Fernández P; Valdebenito-Oyarzo G; Manterola C; Uribe-San-Martín R; Silva C; Henríquez-Ch R; Aboitiz F; Polania R; Guevara P; Muñoz-Venturelli P; Soto-Icaza P; Billeke P
    Sci Rep; 2024 Aug; 14(1):19049. PubMed ID: 39152190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.
    Xiong Q; Xu M; Li J; Liu Y; Zhang J; Xu Y; Dong W
    Clin Microbiol Infect; 2021 Jan; 27(1):89-95. PubMed ID: 32979574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Huang L; Yao Q; Gu X; Wang Q; Ren L; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J; Wang X; Cao B
    Lancet; 2021 Aug; 398(10302):747-758. PubMed ID: 34454673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario.
    McAlister FA; Dong Y; Chu A; Wang X; Youngson E; Quinn KL; Verma A; Udell JA; Yu AYX; Razak F; Ho C; de Mestral C; Ross HJ; van Walraven C; Lee DS;
    CMAJ; 2022 May; 194(19):E666-E673. PubMed ID: 35577377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study.
    Invernizzi A; Renzetti S; van Thriel C; Rechtman E; Patrono A; Ambrosi C; Mascaro L; Corbo D; Cagna G; Gasparotti R; Reichenberg A; Tang CY; Lucchini RG; Wright RO; Placidi D; Horton MK
    Transl Psychiatry; 2024 Oct; 14(1):402. PubMed ID: 39358346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of mental health outcomes in people with covid-19: cohort study.
    Xie Y; Xu E; Al-Aly Z
    BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.